Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
DSIP For research use only
Together, these multidimensional strategies hold promise in dismantling the plastic, drug-tolerant tumor cell states that underlie therapy resistance and disease progression
You know I had to add my own extra, unique touch
Efficacy and safety of once-weekly semaglutide versus exenatide ER in subjects with type 2 diabetes (SUSTAIN 3): a 56-week, open-label, randomized clinical trial
US$ 28.72
US$ 22.20
US$ 27.61
US$ 23.03
US$ 22.54
US$ 28.74
US$ 27.68
